Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

20.30
+0.23001.15%
Post-market: 20.440.1400+0.69%19:53 EDT
Volume:2.81M
Turnover:56.91M
Market Cap:6.48B
PE:42.22
High:20.54
Open:20.19
Low:20.00
Close:20.07
52wk High:21.18
52wk Low:9.56
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.84
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:196.09
PE(LYR):92.27

Loading ...

Amneal Pharma - Phase 4 Data Show Consistent Benefits of Crexont Across All Prior Treatment Groups

THOMSON REUTERS
·
Jun 05

Amneal Announces Full Study Population Interim Phase 4 Elevate-Pd Results, Reinforcing Previously Reported Benefits of Crexont® in Parkinson's Disease

THOMSON REUTERS
·
Jun 05

Is FDA-Backed Romidepsin Launch Reshaping the Investment Case for Amneal Pharmaceuticals (AMRX)?

Simply Wall St.
·
Jun 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 04

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

THOMSON REUTERS
·
Jun 04

Amneal Pharma - Romidepsin Injection Solution Granted 180 Days of Market Exclusivity Under Cgt

THOMSON REUTERS
·
Jun 04

Amneal Pharmaceuticals CEO Chirag Patel to present at Goldman Sachs Global Healthcare Conference

Reuters
·
Jun 01

Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns

Reuters
·
May 30

Amneal Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 20

Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays

TIPRANKS
·
May 20

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Radnet (RDNT) and Relay Therapeutics (RLAY)

TIPRANKS
·
May 20

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Amneal director Deborah M. Autor disposes 34,819 shares worth $450,537.86

Reuters
·
May 13

Amneal Q1 net income more than doubles to $78 million; net revenue rises 3.9% to $722.52 million

Reuters
·
May 08

Amneal Pharmaceuticals held annual shareholder meeting, director nominees elected

Reuters
·
May 08

Amneal Pharmaceuticals Q1 Adj. EPS $0.27 Beats $0.23 Estimate, Sales $722.519M Miss $757.228M Estimate

Benzinga Earnings
·
May 08

Amneal Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 08

Amneal Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 01

Is It Too Late To Reassess Amneal Pharmaceuticals (AMRX) After Its 65% One-Year Surge?

Simply Wall St.
·
Apr 30